A boutique investment bank that few outside of health-care circles knew about has scored a massive victory on Pfizer Inc.’s $43 billion plan to acquire cancer-drug producer Seagen Inc. Photo: Pfizer Head Office, Getty Images MTS Health Partners, which is based in New York, provided financial advice to Seagen in conjunction with boutique investment bank...
All the week’s industry events straight to your inbox.
By signing up you agree to our terms of use and privacy policy.
7 Bell Yard, London, England, WC2A 2JR
You will soon receive a Reset Password link
By signing up you agree to terms of use and privacy policy.
Continue with Facebook Continue with Google